Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’ ...
The partnership is supported by the Michael J. Fox Foundation, which seeks to better understand aSyn protein's role in Parkinson's disease.
Amsterdam, July 22, 2024 – To date Parkinson's disease (PD) is diagnosed clinically and rather late in the course of the disease. There is an urgent need to find an objective, quantifiable biomarker ...
The MarketWatch News Department was not involved in the creation of this content. SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein ...
Researchers show that immune cells transport toxic alpha-synuclein from the gut to the brain, supporting the theory that Parkinson's may start in the gut. The findings identify a new immune-driven ...
After three years of study, the researchers found that alpha-synuclein, a protein closely linked to Parkinson’s disease, ...
Data from the Syn-Sleep Study shows the Syn-One Test detected phosphorylated alpha-synuclein in skin biopsies of 75% of patients with iRBD at baseline This NIH-sponsored, multicenter, prospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results